» Articles » PMID: 16396983

Atypical Expression of Type 2 Iodothyronine Deiodinase in Thyrotrophs Explains the Thyroxine-mediated Pituitary Thyrotropin Feedback Mechanism

Abstract

T(4), the main product of thyroid secretion, is a critical signal in plasma that mediates the TSH-negative feedback mechanism. As a prohormone, T(4) must be converted to T(3) to acquire biological activity; thus, type 2 iodothyronine deiodinase (D2) is expected to play a critical role in this feedback mechanism. However, the mechanistic details of this pathway are still missing because, counterintuitively, D2 activity is rapidly lost in the presence of T(4) by a ubiquitin-proteasomal mechanism. In the present study, we demonstrate that D2 and TSH are coexpressed in rat pituitary thyrotrophs and that hypothyroidism increases D2 expression in these cells. Studies using two murine-derived thyrotroph cells, TtT-97 and TalphaT1, demonstrate high expression of D2 in thyrotrophs and confirm its sensitivity to negative regulation by T(4)-induced proteasomal degradation of this enzyme. Despite this, expression of the Dio2 gene in TalphaT1 cells is higher than their T(4)-induced D2 ubiquitinating capacity. As a result, D2 activity and net T(3) production in these cells are sustained, even at free T(4) concentrations that are severalfold above the physiological range. In this system, free T(4) concentrations and net D2-mediated T(3) production correlated negatively with TSHbeta gene expression. These results resolve the apparent paradox between the homeostatic regulation of D2 and its role in mediating the critical mechanism by which T(4) triggers the TSH-negative feedback.

Citing Articles

Variable transduction of thyroid hormone signaling in structures of the mouse brain.

Sinko R, Salas-Lucia F, Mohacsik P, Halmos E, Wittmann G, Egri P Proc Natl Acad Sci U S A. 2025; 122(6):e2415970122.

PMID: 39903117 PMC: 11831203. DOI: 10.1073/pnas.2415970122.


Natural desiccated thyroid for the treatment of hypothyroidism?.

Heald A, Taylor P, Premawardhana L, Stedman M, Dayan C Front Endocrinol (Lausanne). 2024; 14:1309159.

PMID: 38260143 PMC: 10801060. DOI: 10.3389/fendo.2023.1309159.


Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design.

Premawardhana L, Taylor P, Okosieme O, Adlan M, Obuobie E, Dayan C Front Endocrinol (Lausanne). 2023; 14:1282608.

PMID: 38034018 PMC: 10687631. DOI: 10.3389/fendo.2023.1282608.


Sustained Pituitary T3 Production Explains the T4-mediated TSH Feedback Mechanism.

Batistuzzo A, Salas-Lucia F, Gereben B, Ribeiro M, Bianco A Endocrinology. 2023; 164(12).

PMID: 37864846 PMC: 10637099. DOI: 10.1210/endocr/bqad155.


How does mitochondria function contribute to aerobic performance enhancement in lizards?.

Reardon K, Walton B, Husak J Front Physiol. 2023; 14:1165313.

PMID: 37215170 PMC: 10198381. DOI: 10.3389/fphys.2023.1165313.